The differential binding affinities of the luteinizing hormone (LH)/choriogonadotropin receptor for LH and choriogonadotropin are dictated by different extracellular domain residues

被引:23
作者
Galet, C [1 ]
Ascoli, M [1 ]
机构
[1] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Pharmacol, Iowa City, IA 52242 USA
关键词
D O I
10.1210/me.2004-0410
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The high degree of amino acid sequence homology and the divergent ligand binding affinities of the rat (r) and human ( h) LH receptors (LHRs) allowed us to identify amino acid residues of their extracellular domain that are responsible for the different binding affinities of bovine (b) and hLH, and human choriogonadotropin (hCG) to the hLHR and rLHR. Because of the proposed importance of the beta-sheets of the leucine-rich repeats (LRRs) of the extracellular domain of the LHR on hormone binding, we examined 10 divergent residues present in these regions by analyzing two complementary sets of mutants in which hLHR residues were substituted with the corresponding rLHR residues and vice versa. These experiments resulted in the identification of a single residue ( a Ile or Ser in the C-terminal end of LRR2 of the hLHR or rLHR, respectively) that is important for hLH binding affinity. Surprisingly, however, this residue does not affect hCG or for bLH binding affinity. In fact, the results obtained with bLH and hCG show that several of the divergent residues in the beta-sheets of LRR1-9 affect bLH binding affinity, but none of them affect hCG binding affinity. Importantly, our results also emphasize the involvement of residues outside of the beta-sheets of the LRRs of the LHR in ligand binding affinity. This finding has to be considered in future models of the interaction of LH/CG with the LHR.
引用
收藏
页码:1263 / 1276
页数:14
相关论文
共 24 条
[1]   GONADOTROPIN BINDING AND STIMULATION OF STEROIDOGENESIS IN LEYDIG TUMOR-CELLS [J].
ASCOLI, M ;
PUETT, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1978, 75 (01) :99-102
[2]   The lutropin/choriocrctnadotropin receptor, a 2002 perspective [J].
Ascoli, M ;
Fanelli, F ;
Segaloff, DL .
ENDOCRINE REVIEWS, 2002, 23 (02) :141-174
[3]   Lutropins appear to contact two independent sites in the extracellular domain of their receptors [J].
Bernard, MP ;
Myers, RV ;
Moyle, WR .
BIOCHEMICAL JOURNAL, 1998, 335 :611-617
[4]   Determination of residues important in hormone binding to the extracellular domain of the luteinizing hormone chorionic gonadotropin receptor by site-directed mutagenesis and modeling [J].
Bhowmick, N ;
Huang, JN ;
Puett, D ;
Isaacs, NW ;
Lapthorn, AJ .
MOLECULAR ENDOCRINOLOGY, 1996, 10 (09) :1147-1159
[5]   Identification of ionizable amino acid residues on the extracellular domain of the lutropin receptor involved in ligand binding [J].
Bhowmick, N ;
Narayan, P ;
Puett, D .
ENDOCRINOLOGY, 1999, 140 (10) :4558-4563
[6]   HIGH-EFFICIENCY TRANSFORMATION OF MAMMALIAN-CELLS BY PLASMID DNA [J].
CHEN, C ;
OKAYAMA, H .
MOLECULAR AND CELLULAR BIOLOGY, 1987, 7 (08) :2745-2752
[7]   Transfected cells express mostly the intracellular precursor of the lutropin/choriogonadotropin receptor but this precursor binds choriogonadotropin with high affinity [J].
Fabritz, J ;
Ryan, S ;
Ascoli, M .
BIOCHEMISTRY, 1998, 37 (02) :664-672
[8]   Discovering new hormones, receptors, and signaling mediators in the genomic era [J].
Hsu, SY ;
Hsueh, AJW .
MOLECULAR ENDOCRINOLOGY, 2000, 14 (05) :594-604
[9]  
JENKINSON DH, 2003, TXB RECEPTOR PHARM, P3
[10]   EXPRESSION OF HUMAN LUTEINIZING-HORMONE (LH) RECEPTOR - INTERACTION WITH LH AND CHORIONIC-GONADOTROPIN FROM HUMAN BUT NOT EQUINE, RAT, AND OVINE SPECIES [J].
JIA, XC ;
OIKAWA, M ;
BO, M ;
TANAKA, T ;
NY, T ;
BOIME, I ;
HSUEH, AJW .
MOLECULAR ENDOCRINOLOGY, 1991, 5 (06) :759-768